Takeshi Kuroda

3.1k total citations
152 papers, 2.0k citations indexed

About

Takeshi Kuroda is a scholar working on Rheumatology, Molecular Biology and Surgery. According to data from OpenAlex, Takeshi Kuroda has authored 152 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 43 papers in Molecular Biology and 26 papers in Surgery. Recurrent topics in Takeshi Kuroda's work include Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Systemic Lupus Erythematosus Research (27 papers) and Renal Diseases and Glomerulopathies (22 papers). Takeshi Kuroda is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Systemic Lupus Erythematosus Research (27 papers) and Renal Diseases and Glomerulopathies (22 papers). Takeshi Kuroda collaborates with scholars based in Japan, India and Germany. Takeshi Kuroda's co-authors include Ichiei Narita, Fumitake Gejyo, Masaaki Nakano, Hiroe Sato, Yoko Wada, Satoshi Ito, Minoru Sakatsume, Hisashi Hasegawa, Naohito Tanabe and Masaaki Arakawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Takeshi Kuroda

144 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Kuroda Japan 25 586 581 387 326 266 152 2.0k
Uyen Huynh‐Do Switzerland 26 983 1.7× 260 0.4× 622 1.6× 273 0.8× 232 0.9× 111 2.7k
Louisa Ho Canada 22 438 0.7× 277 0.5× 329 0.9× 222 0.7× 111 0.4× 52 1.7k
Marie‐Christine de Vernejoul France 30 1.3k 2.3× 340 0.6× 476 1.2× 298 0.9× 146 0.5× 80 2.9k
Takashi Kuroiwa Japan 26 600 1.0× 1.0k 1.8× 615 1.6× 248 0.8× 1.0k 3.9× 72 3.2k
Roberto Marcolongo Italy 34 461 0.8× 1.3k 2.2× 147 0.4× 439 1.3× 413 1.6× 129 2.9k
Mei Li China 30 951 1.6× 386 0.7× 600 1.6× 428 1.3× 183 0.7× 215 3.2k
Naoki Matsuoka Japan 27 666 1.1× 421 0.7× 106 0.3× 268 0.8× 478 1.8× 158 2.9k
Rainer Klocke Germany 27 968 1.7× 380 0.7× 88 0.2× 414 1.3× 130 0.5× 70 2.2k
Kathryn M. Thrailkill United States 36 1.5k 2.5× 172 0.3× 305 0.8× 445 1.4× 181 0.7× 75 3.5k
Dong‐Kyu Jin South Korea 33 917 1.6× 396 0.7× 259 0.7× 692 2.1× 260 1.0× 261 3.9k

Countries citing papers authored by Takeshi Kuroda

Since Specialization
Citations

This map shows the geographic impact of Takeshi Kuroda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Kuroda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Kuroda more than expected).

Fields of papers citing papers by Takeshi Kuroda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Kuroda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Kuroda. The network helps show where Takeshi Kuroda may publish in the future.

Co-authorship network of co-authors of Takeshi Kuroda

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Kuroda. A scholar is included among the top collaborators of Takeshi Kuroda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Kuroda. Takeshi Kuroda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kaneko, Yoshikatsu, Hiroe Sato, Daisuke Kobayashi, et al.. (2023). Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus. Lara D. Veeken. 63(5). 1411–1421. 4 indexed citations
3.
Kuroda, Takeshi, Motoyasu Honma, Yukiko Mori, et al.. (2020). Increased Presence of Cerebral Microbleeds Correlates With Ventricular Enlargement and Increased White Matter Hyperintensities in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 12. 13–13. 13 indexed citations
4.
Sato, Hiroe, Chinatsu Takai, Junichiro James Kazama, et al.. (2020). Serum hepcidin level, iron metabolism and osteoporosis in patients with rheumatoid arthritis. Scientific Reports. 10(1). 9882–9882. 29 indexed citations
5.
Kinno, Ryuta, Hirotaka Ochiai, Yukiko Mori, et al.. (2019). The relationship between thyroid function and cerebral blood flow in mild cognitive impairment and Alzheimer’s disease. PLoS ONE. 14(4). e0214676–e0214676. 21 indexed citations
6.
Kuroda, Takeshi, Naohito Tanabe, Hiroe Sato, et al.. (2018). Association between Elevated Mean Corpuscular Volume and C-reactive protein in Patients with Rheumatoid Arthritis. 1(5). 1 indexed citations
7.
Honma, Motoyasu, Yuri Masaoka, Takeshi Kuroda, et al.. (2018). Impairment of cross-modality of vision and olfaction in Parkinson disease. Neurology. 90(11). e977–e984. 8 indexed citations
8.
Hasegawa, Eietsu, Hiroe Sato, Kazue Takai, et al.. (2017). Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome. Lupus. 27(3). 417–427. 11 indexed citations
9.
Murakami, Hidetomo, et al.. (2017). Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease. Neuropsychiatric Disease and Treatment. Volume 13. 2719–2726. 10 indexed citations
10.
Iguchi, Akira, Yoko Wada, Daisuke Kobayashi, et al.. (2012). A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4. Modern Rheumatology. 23(1). 151–155. 16 indexed citations
11.
Kuroda, Takeshi, Naohito Tanabe, Daisuke Kobayashi, et al.. (2012). Treatment with Biologic Agents Improves the Prognosis of Patients with Rheumatoid Arthritis and Amyloidosis. The Journal of Rheumatology. 39(7). 1348–1354. 22 indexed citations
12.
Kuroda, Takeshi, Daisuke Kobayashi, Hiroe Sato, et al.. (2010). Mizoribine therapy in a patient with lupus nephritis: the association between mizoribine concentration and peritoneal dialysis. Modern Rheumatology. 20(3). 296–300. 3 indexed citations
13.
Koyama, Takashi, et al.. (2008). TWO CASES OF VOLVULUS OF THE CECUM IN PATIENTS OF GREAT AGES OVER NINETY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(8). 2011–2015. 2 indexed citations
14.
Kobayashi, Tetsuo, Satoshi Ito, Takeshi Kuroda, et al.. (2007). The Interleukin‐1 and Fcγ Receptor Gene Polymorphisms in Japanese Patients With Rheumatoid Arthritis and Periodontitis. Journal of Periodontology. 78(12). 2311–2318. 57 indexed citations
15.
Kuroda, Takeshi, et al.. (2005). Autoantibodies against oxidized low-density lipoprotein (LDL) and carotid atherosclerosis in patients with rheumatoid arthritis.. PubMed. 23(4). 482–6. 25 indexed citations
16.
Kuroda, Takeshi, Satoshi Ito, Minoru Sakatsume, et al.. (2004). A case of Takayasu arteritis complicated with glomerulonephropathy mimicking membranoproliferative glomerulonephritis. Clinical Rheumatology. 23(6). 536–540. 3 indexed citations
17.
Higuchi, Noboru, Hiroki Maruyama, Takeshi Kuroda, et al.. (2003). Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar–Kyoto rats. Gene Therapy. 10(16). 1297–1310. 31 indexed citations
18.
Kaneko, Yoshikatsu, Minoru Sakatsume, Yuansheng Xie, et al.. (2003). Macrophage Metalloelastase as a Major Factor for Glomerular Injury in Anti-Glomerular Basement Membrane Nephritis. The Journal of Immunology. 170(6). 3377–3385. 41 indexed citations
20.
Meyers-Wallen, Vicki N., T F Manganaro, Takeshi Kuroda, et al.. (1991). The Critical Period for Mullerian Duct Regression in the Dog Embryo1. Biology of Reproduction. 45(4). 626–633. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026